Cronos Group Inc.
CRON Nasdaq Medicinal Chemicals & Botanical Products 金融 FY2017–FY2025
最新收盘价 · 2026年10月23日
$3.35
2.8%Cronos Group Inc. 的业务
暂无业务介绍。
- 法定名称
- Cronos Group Inc.
- 财年结束日
- 2025年12月31日
- 最新年报
- 10-K · 2026年2月26日
- 登记号 · CIK
- 0001656472-26-000016
0001656472
营收与利润率
Cronos Group Inc. 在 2025 财年 营收为 $147M,同比增长 24.6%。
净利润与每股收益
亏损期间以红色显示。
资本回报率
税后营业利润占投入业务资金(债务加股东权益减现金)的比例。
现金流
2025 财年 的自由现金流为 $0.1M,占营收的 0.1%。 经营现金流减资本支出。
股息、回购与股数
Cronos Group Inc. 在 2025 财年 向股东返还 $9.7M,占自由现金流的 6,538%。 稀释股数减少 0.5%。
资产负债表
现金、债务以及显示 Cronos Group Inc. 承担债务能力的指标。
| 财年末 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| 现金及短期投资 | $1.0B | $878M | $862M | $859M | $832M |
| 利息保障倍数 | −10,813.7x | −8,571.4x | — | — | — |
| 流动比率 | 19.9x | 14.1x | 22.5x | 18.8x | 19.6x |
| 速动比率 | 19.3x | 13.5x | 21.8x | 18.2x | 18.6x |
| 总资产 | $1.4B | $1.2B | $1.1B | $1.2B | $1.2B |
| 总负债 | $63.5M | $72.0M | $44.1M | $55.3M | $54.2M |
| 股东权益 | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B |
| 净债务 (− = 净现金) | — | — | — | — | — |
内部人交易
高管、董事和持股超过 10% 的股东在公开市场的买卖,数据来自 Form 4 申报。“计划”表示依据事先制定的 Rule 10b5-1 计划进行的交易。
买入(12 个月)
$0.0M
0 名内部人士
卖出(12 个月)
$0.0M
0 名内部人士
卖出中按计划执行的比例
—
$0.0M
过去 12 个月没有公开市场的内部人交易。
Piotroski F 分数
关于盈利能力、融资和效率的九项通过/未通过测试。8–9 为强,0–2 为弱。
| 测试项 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| 净利润为正 | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ |
| 经营现金流为正 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ |
| 资产回报率上升 | — | — | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ |
| 经营现金流高于净利润 | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ |
| 债务相对资产下降 | — | — | — | — | — | — | — | — | — |
| 流动比率上升 | — | — | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ |
| 股数未增加 | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ |
| 毛利率上升 | — | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ |
| 营收相对资产上升 | — | — | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| F 分数 | — / 3 | — / 5 | 3 / 8 | 3 / 8 | 4 / 8 | 4 / 8 | 4 / 8 | 5 / 8 | 6 / 8 |
| 应计比率 | — | −7.7% | 114.1% | 3.6% | −14.6% | −6.1% | −2.6% | 1.9% | −3.0% |
| Altman Z'' | — | 3.46 | 10.56 | 13.27 | 27.07 | 22.20 | 31.98 | 26.02 | 27.23 |
9 年数据
金额单位为 USD。将鼠标悬停在指标名称上可查看定义。
| 财年 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| 利润表 | |||||||||
| 营收 | $3.1M | $12.1M | $23.8M | $46.7M | $64.6M | $86.7M | $87.2M | $118M | $147M |
| 毛利 | $1.6M | $6.2M | −$17.6M | −$25.8M | −$17.6M | $15.4M | $11.9M | $25.2M | $62.8M |
| 研发支出 | $0.0M | $1.8M | $12.2M | $20.4M | $21.8M | $13.1M | $5.8M | $4.2M | $4.4M |
| 营业利润 | −$6.1M | −$20.4M | −$153M | −$219M | −$292M | −$111M | −$84.8M | −$76.5M | −$17.4M |
| 利息支出 | $0.1M | $0.1M | $1.2M | $0.2M | $0.0M | $0.0M | — | — | — |
| 税前利润 | −$2.3M | −$20.9M | $1.2B | −$73.3M | −$129M | −$121M | −$73.7M | $36.6M | −$17.1M |
| 所得税 | −$0.9M | $0.0M | $0.0M | $1.3M | −$0.4M | $34.2M | −$3.2M | −$3.4M | −$14.2M |
| 净利润 | −$1.5M | −$21.6M | $1.2B | −$73.1M | −$396M | −$169M | −$74.0M | $41.1M | −$9.4M |
| 归属普通股股东的净利润 | −$1.5M | −$20.7M | $1.2B | −$72.5M | — | — | — | — | — |
| 稀释每股收益 | −$0.01 | −$0.12 | $3.33 | −$0.21 | −$1.07 | −$0.45 | −$0.19 | $0.11 | −$0.02 |
| 稀释股数 | 0.18B | 0.17B | 0.34B | 0.35B | 0.37B | 0.38B | 0.38B | 0.39B | 0.38B |
| 现金流 | |||||||||
| 经营现金流 | −$4.3M | −$7.5M | −$131M | −$145M | −$154M | −$88.9M | −$42.8M | $18.8M | $25.9M |
| 资本支出 | $32.9M | $88.3M | $38.7M | $31.4M | $11.1M | $3.5M | $2.5M | $12.4M | $25.7M |
| 自由现金流 | −$37.2M | −$95.8M | −$170M | −$176M | −$165M | −$92.4M | −$45.3M | $6.4M | $0.1M |
| 折旧与摊销 | $0.8M | $1.9M | $4.3M | $7.0M | $15.4M | $13.1M | $8.1M | $9.3M | $14.2M |
| 股权激励 | $1.9M | $8.2M | $11.6M | $15.4M | $10.2M | $15.1M | $8.8M | $8.7M | $7.1M |
| 收购 | $0.0M | $0.0M | $224M | $0.0M | $0.0M | — | — | — | — |
| 股票回购 | — | — | — | — | — | — | $0.0M | $0.0M | $9.7M |
| 股息与回购 | — | — | — | — | — | — | $0.0M | $0.0M | $9.7M |
| 资产负债表 | |||||||||
| 现金及短期投资 | $7.3M | $23.9M | $1.5B | $1.3B | $1.0B | $878M | $862M | $859M | $832M |
| 流动资产 | — | $39.9M | $1.6B | $1.4B | $1.1B | $960M | $933M | $936M | $944M |
| 流动负债 | — | $33.3M | $333M | $207M | $54.4M | $68.1M | $41.4M | $49.7M | $48.2M |
| 存货 | — | $7.4M | $38.0M | $44.0M | $32.8M | $37.6M | $30.5M | $33.1M | $46.8M |
| 固定资产净额 | — | $126M | $160M | $188M | $74.1M | $60.6M | $59.5M | $133M | $146M |
| 商誉 | $1.4M | $1.3M | $214M | $180M | $1.1M | $1.0M | $1.1M | $63.5M | $66.5M |
| 无形资产 | — | $8.2M | $71.2M | $69.7M | $18.1M | $26.7M | $21.1M | $11.3M | $8.9M |
| 总资产 | — | $183M | $2.1B | $1.9B | $1.4B | $1.2B | $1.1B | $1.2B | $1.2B |
| 总负债 | — | $34.9M | $341M | $218M | $63.5M | $72.0M | $44.1M | $55.3M | $54.2M |
| 股东权益 | $63.7M | $148M | $1.7B | $1.7B | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B |
| 利润率 | |||||||||
| 毛利率 | 50.0% | 51.3% | −74.1% | −55.3% | −27.3% | 17.8% | 13.7% | 21.4% | 42.8% |
| 营业利润率 | −194.5% | −168.7% | −645.5% | −469.6% | −452.2% | −128.4% | −97.2% | −65.1% | −11.9% |
| EBITDA 利润率 | −170.1% | −152.7% | −627.6% | −454.5% | −428.4% | −113.3% | −87.9% | −57.1% | −2.2% |
| 净利率 | −47.1% | −178.5% | 4,911.6% | −156.5% | −613.5% | −194.5% | −84.8% | 34.9% | −6.4% |
| 自由现金流利润率 | −1,182.2% | −790.6% | −715.2% | −377.3% | −255.2% | −106.5% | −52.0% | 5.5% | 0.1% |
| 回报率 | |||||||||
| 已动用资本回报率 | — | −13.6% | −8.7% | −12.8% | −21.7% | −9.7% | −7.7% | −6.9% | −1.5% |
| 股本回报率 | −2.3% | −20.4% | 122.9% | −4.2% | −26.0% | −13.6% | −6.6% | 3.8% | −0.9% |
| 资产回报率 | — | −11.8% | 102.6% | −3.6% | −23.8% | −12.9% | −6.3% | 3.6% | −0.8% |
| 有形股本回报率 | −2.4% | −14.9% | 79.7% | −5.0% | −30.1% | −15.1% | −6.9% | 4.2% | −0.9% |
| 增长 | |||||||||
| 营收增长 | — | 285.2% | 95.9% | 96.7% | 38.2% | 34.4% | 0.6% | 34.8% | 24.6% |
| 净利润增长 | — | — | — | −106.3% | — | — | — | — | −123.0% |
| 每股收益增长 | — | — | — | −106.3% | — | — | — | — | −118.2% |
| 自由现金流增长 | — | — | — | — | — | — | — | — | −97.7% |
| 股数变化 | — | −2.6% | 99.0% | 2.6% | 5.4% | 1.8% | 1.1% | 1.2% | −0.5% |
| 财务健康 | |||||||||
| 利息保障倍数 | −60.6x | −147.1x | −123.2x | −1,179.5x | −10,813.7x | −8,571.4x | — | — | — |
| 流动比率 | — | 1.2x | 4.7x | 6.6x | 19.9x | 14.1x | 22.5x | 18.8x | 19.6x |
| 速动比率 | — | 1.0x | 4.6x | 6.4x | 19.3x | 13.5x | 21.8x | 18.2x | 18.6x |
| 资本配置 | |||||||||
| 资本支出 / 营收 | 1,046.3% | 728.6% | 162.8% | 67.2% | 17.3% | 4.0% | 2.9% | 10.6% | 17.5% |
| 股权激励 / 营收 | 61.4% | 67.2% | 48.9% | 32.9% | 15.7% | 17.4% | 10.1% | 7.4% | 4.8% |
| 股东回报 / 自由现金流 | — | — | — | — | — | — | — | 0.0% | 6,537.6% |
| 质量评分 | |||||||||
| Piotroski F 分数 | — | — | 3.0 | 3.0 | 4.0 | 4.0 | 4.0 | 5.0 | 6.0 |
| Altman Z'' | — | 3.5 | 10.6 | 13.3 | 27.1 | 22.2 | 32.0 | 26.0 | 27.2 |
| 应计比率 | — | −7.7% | 114.1% | 3.6% | −14.6% | −6.1% | −2.6% | 1.9% | −3.0% |
来源:SEC EDGAR XBRL 文件 (CIK 0001656472). 数据更新于 2026年10月24日。 第四季度数据为全年减去前九个月。 仅供参考,不构成投资建议。依赖任何数字前,请核对原始文件。
